1 / 20

The origins of clinical / academic collaboration in Colchester: a steady state or a big bang?

The origins of clinical / academic collaboration in Colchester: a steady state or a big bang?. Simon Marsh Consultant Surgeon and Honorary Senior Lecturer. The Essex University MD Scheme The Steady State Origins. Elena Klenova John Norton Simon Marsh Tan Arulampalan

roman
Download Presentation

The origins of clinical / academic collaboration in Colchester: a steady state or a big bang?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The origins of clinical / academic collaboration in Colchester: a steady state or a big bang? Simon Marsh Consultant Surgeon and Honorary Senior Lecturer

  2. The Essex University MD Scheme The Steady State Origins

  3. Elena Klenova John Norton Simon Marsh Tan Arulampalan Phil Murray Neil Rothnie Anne Robinson Andrew Poynter Chris Scrase Siobhan Hart Frederick Gay Mark Jorge Tony Elston Paul Kelly Okansa Hoile Linda Fox David Todd Debo Ademokum Metodi Metodiev Murray Griffin Valerie Gladwell Ralph Beneke Terry McGenity Paul Bromley Gavin Sandercock Dominic Micklewright Corinne Whitby

  4. Breast cancer Colorectal cancer Neuropsychology Haematology Prostate cancer Sports and exercise medicine Back pain Cardiac rehabilitation Physiotherapy Cardiorespiratory physiology Microbiology

  5. Colchester Hospitals University NHS Foundation Trust Ipswich Hospital NHS Trust Southend University Hospital NHS Foundation Trust

  6. How to set up an MD programme Desire Drive Stubbornness Imperative

  7. European Working Time Directive

  8. What you need: Right person: Clinical experience Money: University fees Salary Enterprise(!)

  9. Colorectal Research Fellows: James Wright 2002-4 Nicholas Ward 2004-6 Christopher Liao 2006-8 Nikhil Pawa 2008-10 Justine Lawrence 2010-12 Breast Research Fellows Naresh Pore 2005-7 Adhip Mandal 2007-9 Anu Apote 2009-11

  10. So, what’s the point? The Doctor The Hospital The University Me

  11. MD Thesis ASSESSMENT OF THE UTILITY OF BORIS PROTEIN AS A BLOOD AND TISSUE BIOMARKER OF BREAST CANCER.

  12. Papers The potential of BORS detected in the leukocytes of breast cancer patients As an early marker of tumourigenesis Human Cancer Biology BORIS a paralogue of the transcription factor, CTFC, is aberrantly expressed In breast tumours British Journal of Cancer

  13. Abstracts BORIS (Brother of Regulator of Imprinting Sites) as a possible new blood marker for breast cancer European Journal of Surgical Oncology BORIS- A true indicator of clear margins and predictor of local recurrence? European Journal of Surgical Oncology BORIS as a possible new Blood Marker for Breast Cancer. European Journal of Surgical Oncology

  14. Posters BORIS: a new potential peripheral biomarker for breast cancer; evaluation of its role in surveillance, diagnosis and prognosis. San Diego, California Significance of BORIS (Brother of Regulator of Imprinted Sites) expression to chemotherapy in breast cancer patients Miami, Florida BORIS- A true indicator of clear margins and predictor of local recurrence? Miami, Florida BORIS as a possible new Blood Marker for Breast Cancer Miami, Florida BORIS (Brother of Regulator of Imprinting Sites) as a possible new Blood Marker for Breast Cancer RCS London

  15. Now

More Related